Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy

  1. Fernandez-Rivas, M.
  2. Vereda, A.
  3. Vickery, B.P.
  4. Sharma, V.
  5. Nilsson, C.
  6. Muraro, A.
  7. Hourihane, J.O.B.
  8. DunnGalvin, A.
  9. du Toit, G.
  10. Blumchen, K.
  11. Beyer, K.
  12. Smith, A.
  13. Ryan, R.
  14. Adelman, D.C.
  15. Jones, S.M.
Aldizkaria:
Allergy: European Journal of Allergy and Clinical Immunology

ISSN: 1398-9995,  0105-4538

Argitalpen urtea: 2022

Alea: 77

Zenbakia: 3

Orrialdeak: 991-1003

Mota: Artikulua

DOI: 10.1111/ALL.15027 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus